InvestorsHub Logo
Followers 46
Posts 2353
Boards Moderated 0
Alias Born 06/11/2020

Re: None

Tuesday, 07/26/2022 9:02:05 PM

Tuesday, July 26, 2022 9:02:05 PM

Post# of 4271
Latest from a Call with ADMP CEO...........

1. AGNY ongoing and hopes to wrap up end of year with investigation from last year horse mess.

2_ PPT second loan ADMP took had to be given back 2 million charge allocated last Q set aside for said reason,This was Covid funds.

3= Symjepi voluntary recall on 4 lots due to metal found in liquid at subcontractor Mfg plant.Plant issued FDA warning letter looking for return by fall sometime.

4=USC in AR still for sale-has final discussion with a buyer in the wings 2.-3mm selling price net to ADMP.



5 -No early ZIMHI numbers for upcoming Quarter expect them from USWM soon.revenue will be said at ER on Aug 15th

6 A future partner for ZIMHI overseas appears to not be the way to go due to cost and nees as they See USA the hotspot for sales.

7. As of a month or so ago 200 patients have been enrolled.David swore this had been relayed to shareholders but Caller said NO it has NOT.

8-Sept early is when DSMB will meet for an update-which is weeks after Aug 15 ER.

9- An off the cuff comment was made ADMP looking to add a NEW Compound to Injector to treat something new??? All that was said about it.

10-14 mil cash on hand- as Caller has sent in another email asking if indeed NIH grant is funding the current Tempol Trial and how do we get reimbursed ADMP has paid along the way for the Tempol trial/

11- ADMP looking at Cold-Flu- Asthma for Tempol NEW trial-one of those or more over time.

12. ADMP can sell 15 million more shares from the existing authorized shelf.

13-ADMP CEO painted the broke picture really could use the YES votes...Caller said NO vote still remains NO after the call was over...